Analysis of Class Action Law Suits Against Merck for Vioxx

A former chief scientist of Merck & Co. had concerns about the cardiovascular safety of painkiller Vioxx years before the company pulled it off the market, according to a videotaped deposition played in court few days before in a Vioxx product liability trial.

But Edward Scolnick, president of Merck Research Laboratories until he retired in 2002, also was upset about pressure from the Food and Drug Administration to put safety warnings on the blockbuster arthritis drug.

Full article »


Protected by Comment Guard Pro